Cargando…

SARS-CoV-2 Infection and Response to COVID-19 Vaccination in Patients With Primary Immunodeficiencies

Primary immunodeficiencies (PIDs) are heterogeneous, rare disorders that increase susceptibility to infection and/or immune dysregulation. Individuals with certain PIDs are at high risk of severe or fatal outcomes from SARS-CoV-2 infections (the causative agent of COVID-19), either due to the underl...

Descripción completa

Detalles Bibliográficos
Autor principal:	Paris, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	COVID-19 Vaccination Supplement
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401615/ https://www.ncbi.nlm.nih.gov/pubmed/37539759 http://dx.doi.org/10.1093/infdis/jiad145

Ejemplares similares

Susceptibility to SARS-CoV-2 Infection and Immune Responses to COVID-19 Vaccination Among Recipients of Solid Organ Transplants
por: Subramanian, Vijay
Publicado: (2023)

Susceptibility to COVID-19 and Immunologic Response to Vaccination in Patients With Immune-Mediated Inflammatory Diseases
por: Finckh, Axel, et al.
Publicado: (2023)

COVID-19 Vaccination in Patients With Cancer and Patients Receiving HSCT or CAR-T Therapy: Immune Response, Real-World Effectiveness, and Implications for the Future
por: Hall, Victoria G, et al.
Publicado: (2023)

COVID-19 Vaccination Among Patients Receiving Maintenance Renal Replacement Therapy: Immune Response, Real-World Effectiveness, and Implications for the Future
por: Rouphael, Nadine, et al.
Publicado: (2023)

The Burden of COVID-19 in the Immunocompromised Patient: Implications for Vaccination and Needs for the Future
por: Antinori, Andrea, et al.
Publicado: (2023)

A Call to Action: Current Challenges and Considerations for COVID-19 Vaccination in Immunocompromised Populations
por: Bonanni, Paolo, et al.
Publicado: (2023)

COVID-19 Vaccination Associated With Reduced Postoperative SARS-CoV-2 Infection and Morbidity
por: Prasad, Nikhil K., et al.
Publicado: (2022)

SARS-CoV-2 vaccine-related neurological complications
por: Oonk, Nicol G. M., et al.
Publicado: (2022)

Neurological Complications of SARS-CoV, MERS-CoV, and COVID-19
por: Alshebri, Munirah Saad, et al.
Publicado: (2020)

Infections sévères à SARS-CoV-2
por: Taghboulit, N., et al.
Publicado: (2021)

Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity
por: Delmonte, Ottavia M., et al.
Publicado: (2021)

Humoral and Cellular Immune Responses to SARS–CoV‐2 Infection and Vaccination in Autoimmune Disease Patients With B Cell Depletion
por: Simon, David, et al.
Publicado: (2021)

Simultaneous analysis of antigen‐specific B and T cells after SARS‐CoV‐2 infection and vaccination
por: Newell, Krista L., et al.
Publicado: (2022)

Diaphragmatic myoclonus due to SARS-CoV-2 infection
por: Borroni, Barbara, et al.
Publicado: (2020)

Humoral antibody kinetics with ChAdOx1-nCOV (Covishield™) and BBV-152 (Covaxin™) vaccine among Indian Healthcare workers: A 6-month longitudinal cross-sectional Coronavirus Vaccine-induced antibody titre (COVAT) study
por: Singh, Awadhesh Kumar, et al.
Publicado: (2022)

Important Steps to Control COVID-19/SARS-CoV-2 Infection
por: Chatterjee, Sudipto
Publicado: (2020)

Clinical severity according to the primary infection variant in patients with suspected SARS-CoV-2 reinfection in Korea
por: Hwang, Myung-Jae, et al.
Publicado: (2022)

The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression
por: Pivniouk, Vadim, et al.
Publicado: (2022)

ADEM anti-MOG antibody-positive after SARS-CoV2 vaccination
por: Mumoli, Laura, et al.
Publicado: (2021)

Isolated musculocutaneous involvement in neuralgic amyotrophy associated with SARS-CoV2 vaccination
por: Civardi, Carlo, et al.
Publicado: (2022)

Foreword: Preventing COVID-19 Among the Immunocompromised Population
por: Willicombe, Michelle
Publicado: (2023)

Protective Effects of CVD and DM Medications in SARS-CoV-2 Infection
por: Bangi, Shifa, et al.
Publicado: (2020)

First motor seizure as presenting symptom of SARS-CoV-2 infection
por: Fasano, Antonio, et al.
Publicado: (2020)

Air filtration and SARS-CoV-2
por: Nazarenko, Yevgen
Publicado: (2020)

Autoimmune encephalitis following ChAdOx1-S SARS-CoV-2 vaccination
por: Kwon, Hyeryung, et al.
Publicado: (2021)

Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events
por: Ng, Siew C, et al.
Publicado: (2022)

Safety of SARS-CoV-2 vaccines in patients with myasthenia gravis: a meta-analysis
por: Zheng, Qian, et al.
Publicado: (2023)

Real-life Evidence of Lower Lung Virulence in COVID-19 Inpatients Infected with SARS-CoV-2 Omicron Variant Compared to Wild-Type and Delta SARS-CoV-2 Pneumonia
por: Trunfio, Mattia, et al.
Publicado: (2022)

Colitis as a Sole Presentation of SARS-CoV-2 Infection: Case Report
por: Jaijakul, Siraya
Publicado: (2020)

Portal Vein Thrombosis—a Rare Complication of SARS-CoV-2 Infection
por: Sharma, Neeraj, et al.
Publicado: (2021)

SARS-CoV-2 breakthrough infections among hospitalized patients in southeastern Michigan
por: Fine, Sydney, et al.
Publicado: (2022)

Atrial fibrillation is related to higher mortality in COVID-19/SARS-CoV-2 pneumonia infection
por: Denegri, Andrea, et al.
Publicado: (2021)

Phenotypic analysis of the pediatric immune response to SARS‐CoV‐2 by flow cytometry
por: Sibbertsen, Freya, et al.
Publicado: (2022)

Viral shedding patterns of symptomatic SARS-CoV-2 infections by periods of variant predominance and vaccination status in Gyeonggi Province, Korea
por: Choi, Gawon, et al.
Publicado: (2022)

Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab
por: Gallo, Antonio, et al.
Publicado: (2021)

B Cell Numbers Predict Humoral and Cellular Response Upon SARS–CoV‐2 Vaccination Among Patients Treated With Rituximab
por: Stefanski, Ana‐Luisa, et al.
Publicado: (2022)

A Systematic Review of the Protective Effect of Prior SARS-CoV-2 Infection on Repeat Infection
por: Kojima, N., et al.
Publicado: (2021)

Association between stopping universal SARS-CoV-2 admission testing and hospital-onset SARS-CoV-2 in England and Scotland
por: Pak, Theodore, et al.
Publicado: (2023)

Delayed Parosmia Following SARS-CoV-2 Infection: a Rare Late Complication of COVID-19
por: Duyan, Murat, et al.
Publicado: (2021)

COVID‐19 elicits an impaired antibody response against SARS‐CoV‐2 in patients with haematological malignancies
por: Passamonti, Francesco, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hhtucvu6os0egio8p31ec60u8j